Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Piericones A and B as Potent Antithrombotics: Nanomolar Noncompetitive Protein Disulfide Isomerase Inhibitors with an Unexpected Chemical Architecture.

Journal of the American Chemical Society·2023

Same author

Characterization of Microstructural Evolution in Heat-Affected Zone of Cu-Bearing Ultra-High-Strength Steel with Lamellar Microstructure.

Materials (Basel, Switzerland)·2023

Same author

Decomposition of Total Organic Halogen Formed during Chlorination: The Iceberg of Halogenated Disinfection Byproducts Was Previously Underestimated.

Environmental science & technology·2023

Same author

First evidence of meso- and microplastics on the mangrove leaves ingested by herbivorous snails and induced transcriptional responses.

The Science of the total environment·2023

Same author

Diverse flowering responses subjecting to ambient high temperature in soybean under short-day conditions.

Plant biotechnology journal·2022

Same author

Crosstalk Suppression in Individually Addressed Two-Qubit Gates in a Trapped-Ion Quantum Computer.

Physical review letters·2022

Search research articles

Related Experiment Video

Updated: Jun 14, 2025

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

Liposomes-enabled cancer chemoimmunotherapy.

Lele Zhang¹, Jiangpei Shi¹, Mao-Hua Zhu¹

¹Hongqiao International Institute of Medicine, Tongren Hospital and State Key Laboratory of Systems Medicine for Cancer, Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

|September 5, 2024

Summary

Liposomes enhance chemoimmunotherapy for cancers like lung and breast cancer by improving targeted drug delivery. This approach shows promise in reducing adverse events and increasing treatment success rates.

Keywords:

Biomimetic Cancer therapy Chemoimmunotherapy Liposomes PD-L1

More Related Videos

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

Related Experiment Videos

Last Updated: Jun 14, 2025

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

Area of Science:

Oncology
Nanomedicine
Immunology

Background:

Chemoimmunotherapy is a promising cancer treatment but faces limitations due to adverse events and poor drug distribution.
Targeted drug delivery systems are crucial for overcoming these limitations.

Purpose of the Study:

To review the progress of liposome-enabled chemoimmunotherapy in preclinical and clinical settings.
To discuss the challenges and future directions for liposome-based cancer treatments.

Main Methods:

Literature review of preclinical studies and clinical trials on liposome-based chemoimmunotherapy.
Analysis of therapeutic outcomes and adverse events associated with liposome formulations.

Main Results:

Liposomes show significant potential as nanocarriers for chemoimmunotherapy, improving targeted delivery.
Liposome-enabled chemoimmunotherapy has demonstrated impressive therapeutic outcomes in various cancers.
Progress has been made in clinical translation, with notable successes.

Conclusions:

Liposomes represent a key advancement in cancer chemoimmunotherapy, offering improved efficacy and safety.
Further research and development are needed to address existing challenges and optimize liposome-based treatments for broader clinical application.